摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-丁基-3-氨基吡嗪 | 91678-85-2

中文名称
2-丁基-3-氨基吡嗪
中文别名
——
英文名称
2-amino-3-butylpyrazine
英文别名
3-Butylpyrazin-2-amine
2-丁基-3-氨基吡嗪化学式
CAS
91678-85-2
化学式
C8H13N3
mdl
——
分子量
151.211
InChiKey
KGFKAUJGEFCTQE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    278.9±35.0 °C(Predicted)
  • 密度:
    1.050±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    51.8
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    2-bromo-2-(4-fluorophenyl)-1-(4-methylsulfonylphenyl)ethanone2-丁基-3-氨基吡嗪N,N-二甲基甲酰胺 为溶剂, 生成 8-Butyl-3-(4-fluoro-phenyl)-2-(4-methanesulfonyl-phenyl)-imidazo[1,2-a]pyrazine
    参考文献:
    名称:
    Synthesis and SAR of a New Series of COX-2-Selective Inhibitors:  Pyrazolo[1,5-a]pyrimidines
    摘要:
    The synthesis and pharmacological activity of a series of bicyclic pyrazolo[1,5-a]pyrimidines as potent and selective cyclooxygenase-2 (COX-2) inhibitors are described. The new compounds were evaluated both in vitro (COX-1 and COX-2 inhibition in human whole blood) and in vive (carrageenan-induced paw edema and air-pouch model). Modification of the pyrimidine substituents showed that 6,7-disubstitution provided the best activity and led to the identification of 3-(4-fluorophenyl)-6,7-dimethyl-2-(4-methylsulfonylphenyl)pyrazolo[1,5-a]pyrimidine (10f) as one of the most potent and selective COX-2 inhibitor in this series.
    DOI:
    10.1021/jm0009383
点击查看最新优质反应信息

文献信息

  • HETEROCYCLYL-SUBSTITUTED ANTI-HYPERCHOLESTEROLEMIC COMPOUNDS
    申请人:Morriello Gregori J.
    公开号:US20100069347A1
    公开(公告)日:2010-03-18
    This invention provides cholesterol absorption inhibitors of Formula I: and the pharmaceutically acceptable salts thereof, wherein R 12 is a hydroxylated alkyl group and R 9 contains a heterocyclic ring. The compounds are useful for lowering plasma cholesterol levels, particularly LDL cholesterol, and for treating atherosclerosis and preventing atherosclerotic disease events.
    本发明提供了I式胆固醇吸收抑制剂及其药学上可接受的盐,其中R12是一个羟基化的烷基基团,而R9包含一个杂环环。这些化合物对降低血浆胆固醇水平,特别是低密度脂蛋白胆固醇,以及治疗动脉粥样硬化和预防动脉粥样硬化疾病事件具有用处。
  • Heterocyclo inhibitors of potassium channel function
    申请人:Bristol-Myers Squibb Company
    公开号:EP2228065A2
    公开(公告)日:2010-09-15
    Novel heterocyclo compounds of formulae (i), (ii) and (iii) useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.
    式(i)、(ii)和(iii)的新型杂环化合物,可用作钾通道功能抑制剂(特别是电压门控K+通道Kv1亚族的抑制剂,尤其是与超快速活化延迟整流K+电流IKur有关的Kv1.5抑制剂),使用此类化合物预防和治疗心律失常和IKur相关疾病的方法,以及含有此类化合物的药物组合物。
  • Verfahren zur Herstellung von 2-Halogen- und 2-Cyanpyrazinen
    申请人:BASF Aktiengesellschaft
    公开号:EP0111160B1
    公开(公告)日:1986-10-22
  • Synthesis and SAR of a New Series of COX-2-Selective Inhibitors:  Pyrazolo[1,5-<i>a</i>]pyrimidines
    作者:Carmen Almansa、Alberto F. de Arriba、Fernando L. Cavalcanti、Luis A. Gómez、Agustí Miralles、Manuel Merlos、Julián García-Rafanell、Javier Forn
    DOI:10.1021/jm0009383
    日期:2001.2.1
    The synthesis and pharmacological activity of a series of bicyclic pyrazolo[1,5-a]pyrimidines as potent and selective cyclooxygenase-2 (COX-2) inhibitors are described. The new compounds were evaluated both in vitro (COX-1 and COX-2 inhibition in human whole blood) and in vive (carrageenan-induced paw edema and air-pouch model). Modification of the pyrimidine substituents showed that 6,7-disubstitution provided the best activity and led to the identification of 3-(4-fluorophenyl)-6,7-dimethyl-2-(4-methylsulfonylphenyl)pyrazolo[1,5-a]pyrimidine (10f) as one of the most potent and selective COX-2 inhibitor in this series.
查看更多